Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Pulmonary Function Testing Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Cart-Based PFT Systems and Stationary PFT Systems), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximum Voluntary Ventilation, Oxygen Titration Test, and Others), Component (Hardware, Software, and Services), Application (Chronic Obstructive Pulmonary Disorder, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), and End User (Hospitals, Specialty Clinics, and Diagnostic Laboratories)
- Report Code : TIPRE00017822
- Pages : 220
The global pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.
The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.
The global pulmonary function testing systems market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the pulmonary function testing systems market in 2021. The US held the largest market share of the North America pulmonary function test systems market. The market is expected to grow due to an increase in the prevalence of lung cancer and a rise in technological advancements and developments by companies across the country.
Growing Prevalence of Occupational Lung Diseases
Occupational lung disease is one of the most influential factors accelerating the demand for pulmonary function testing systems. As per The Johns Hopkins University 2023 report, repeated and long-term exposure to certain irritants on the job can lead to lung disease with long-lasting effects on the patients. For example, in certain occupations, people are more at risk of occupational lung diseases due to the nature of the location, work, and environment. Additionally, people working in a car garage or textile factory may be exposed to hazardous chemicals, dust, and fibers that result in lifetime lung problems if not diagnosed and treated. Moreover, asbestosis is caused by the inhalation of microscopic fibers of asbestos with disease progression and resulting in scarring of the lungs of people working in construction, manufacturing, and chemical refining. According to the American Lung Association, an estimated 1.3 million construction and industry workers are exposed to asbestos.
Pulmonary function testing plays a critical role in determining occupational lung disease among workers. As per the American College of Occupational and Environmental Medicine 2020 report, spirometry in the occupational health setting plays a critical role in the primary, secondary, and tertiary prevention of workplace-related lung disease. The aim of workplace spirometry is to identify workers who require further evaluation for occupational lung-related disorders. As spirometry testing is intended for both screening and clinical evaluations at the workplace, it is performed at small clinical practices, small-sized industries, and multiple plant medical departments within an industry. Further, to recognize the central role of spirometry in workplace respiratory programs, the American College of Occupational and Environmental Medicine (ACOEM) developed three spirometry position statements that advanced the occupational health practice.
Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held the largest share of the market in 2022. Moreover, the cart-based segment is anticipated to register the highest CAGR in the market during the forecast period. The increasing prevalence of lung diseases is one of the major driving factors promoting the market growth for the portable PFT system segment. Furthermore, technological advancements in portable PFT systems and increasing availability of these advanced products are driving the market for the portable PFT system segment. In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period. Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. Moreover, the software segment is anticipated to register the highest CAGR in the market during the forecast period. Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lung diseases, and others. The chronic obstructive pulmonary disease (COPD) segment is held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. Moreover, the specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Dubai Health Authority, National Lung Health Education Program, Center for Disease Control and Prevention, European Respiratory Society, Organization for Economic Cooperation and Development, and Globocan are among the major primary and secondary sources referred to while preparing the report on the pulmonary function testing systems market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pulmonary Function Testing Systems Market – By Type
1.3.2 Global Pulmonary Function Testing Systems Market – By Test Type
1.3.3 Global Pulmonary Function Testing Systems Market – By Component
1.3.4 Global Pulmonary Function Testing Systems Market – By Application
1.3.5 Global Pulmonary Function Testing Systems Market – By End User
1.3.6 Global Pulmonary Function Testing Systems Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pulmonary Function Testing Systems Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Experts’ Opinion
5. Pulmonary Function Testing Systems Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lung-Related Disorders
5.1.2 Occupational Lung Diseases
5.2 Market Restraints
5.2.1 Risk of Cross-Contamination and Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Home Healthcare Pulmonary Function Testing Systems
5.4 Future Trends
5.4.1 Technological Advancements in Pulmonary Function Testing Systems
5.5 Impact Analysis
6. Pulmonary Function Testing Systems Market– Global Analysis
6.1 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.2 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1.1 MGC Diagnostics
6.3.1.2 Vyaire Medical Inc
7. Pulmonary Function Testing Systems Market Analysis – By Type
7.1 Overview
7.2 Pulmonary Function Testing Systems Market, By Type, 2021 & 2028 (%)
7.3 Cart-Based PFT Systems
7.3.1 Overview
7.3.2 Cart-Based PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Stationary PFT Systems
7.4.1 Overview
7.4.2 Stationary PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8. Pulmonary Function Testing Systems Market Analysis – By Test Type
8.1 Overview
8.2 Pulmonary Function Testing Systems Market, By Test Type, 2021 & 2028 (%)
8.3 Spirometry
8.3.1 Overview
8.3.2 Spirometry: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Lung Volume
8.4.1 Overview
8.4.2 Lung Volume: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Gas Exchange Testing
8.5.1 Overview
8.5.2 Gas Exchange Testing: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Maximal Voluntary Ventilation
8.6.1 Overview
8.6.2 Maximal Voluntary Ventilation: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Oxygen Titration Test
8.7.1 Overview
8.7.2 Oxygen Titration Test: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others Test
8.8.1 Overview
8.8.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9. Pulmonary Function Testing Systems Market Analysis – By Component
9.1 Overview
9.2 Pulmonary Function Testing Systems Market, By Component, 2021 & 2028 (%)
9.3 Hardware
9.3.1 Overview
9.3.2 Hardware: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Software
9.4.1 Overview
9.4.2 Software: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Services
9.5.1 Overview
9.5.2 Services: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10. Pulmonary Function Testing Systems Market Analysis – By Application
10.1 Overview
10.2 Pulmonary Function Testing Systems Market, By Application, 2021 & 2028 (%)
10.3 Chronic Obstructive Pulmonary Disease
10.3.1 Overview
10.3.2 Chronic Obstructive Pulmonary Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Asthma
10.4.1 Overview
10.4.2 Asthma: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Chronic Shortness of Breath
10.5.1 Overview
10.5.2 Chronic Shortness of Breath: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Restrictive Lung Disease
10.6.1 Overview
10.6.2 Restrictive Lung Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11. Pulmonary Function Testing Systems Market Analysis – By End-User
11.1 Overview
11.2 Pulmonary Function Testing Systems Market, By End-User, 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Diagnostic Laboratories
11.5.1 Overview
11.5.2 Diagnostic Laboratories: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
12. Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 – Geographic Analysis
12.1 North America: Pulmonary Function Testing Systems Market
12.1.1 Overview
12.1.2 North America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.4 North America: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.5 North America: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.6 North America: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7 North America: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.1 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.1 Overview
12.1.7.1.2 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.3 US: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.1.4 US: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.1.5 US: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.1.6 US: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.1.7 US: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.1 Overview
12.1.7.2.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.3 Canada: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.2.4 Canada: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.2.5 Canada: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.2.6 Canada: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.2.7 Canada: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.3 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.1 Overview
12.1.7.3.2 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.3 Mexico: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.3.4 Mexico: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.3.5 Mexico: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.3.6 Mexico: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.3.7 Mexico: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2 Europe: Pulmonary Function Testing Systems Market
12.2.1 Overview
12.2.2 Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.4 Europe: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.5 Europe: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.6 Europe: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.7 Europe: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8 Europe: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.2.8.1 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.3 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.3.5 France: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.3.6 France: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.3.7 France: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.4 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.5 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.6.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.6.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.6.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.6.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3 Asia Pacific: Pulmonary Function Testing Systems Market
12.3.1 Overview
12.3.2 Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.4 Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.5 Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.6 Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.7 Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.3.8.1 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 Overview
12.3.8.1.2 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.3 China: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.1.4 China: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.1.5 China: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.1.6 China: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.1.7 China: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.1 Overview
12.3.8.2.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.3 Japan: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.2.4 Japan: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.2.5 Japan: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.2.6 Japan: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.2.7 Japan: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.3 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.1 Overview
12.3.8.3.2 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.3 India: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.3.4 India: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.3.5 India: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.3.6 India: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.3.7 India: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.4 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.3 South Korea: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.4.4 South Korea: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.4.5 South Korea: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.4.6 South Korea: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.4.7 South Korea: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.5 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.3 Australia: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.5.4 Australia: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.5.5 Australia: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.5.6 Australia: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.5.7 Australia: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.3 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.4 Middle East & Africa Exoskeleton Robotic System Market
12.4.1 Overview
12.4.2 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.3 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.4 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.5 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.6 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.7 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End Use (US$ Mn)
12.4.8 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Country (%)
12.4.8.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.2 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.1.3 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.1.4 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.1.5 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.1.6 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.1 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.2.3 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.2.4 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.2.5 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.2.6 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.1 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.2 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.3.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.3.4 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.3.5 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.3.6 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.4 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.1 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.2 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.4.3 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.4.4 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.4.5 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.4.6 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.5 South & Central America Pulmonary Function Testing Systems Market
12.5.1 Overview
12.5.2 South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.3 South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.4 South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.5 South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.6 South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.7 South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8 South & Central America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.5.8.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.2 Brazil: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.1.3 Brazil: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.1.4 Brazil: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.1.5 Brazil: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.1.6 Brazil: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.2 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.1 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.2 Argentina: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.2.3 Argentina: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.2.4 Argentina: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.2.5 Argentina: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.2.6 Argentina: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.3 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.1 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.2 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.3.3 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.3.4 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.3.5 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.3.6 Rest of South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Pulmonary Function Testing Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic
14. Global Pulmonary Function Testing Systems Market – Industry Landscape
14.1 Overview
14.2 Growth Strategies in Pulmonary Function Testing Systems Market
14.3 Organic Growth Strategies
14.3.1 Overview
14.4 Inorganic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 COSMED Srl
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MGC Diagnostics Corp
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Morgan Scientific Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Minato Medical Science Co Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Schiller AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Chest MI Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Vyaire Medical Inc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 ndd Medical Technologies Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 PulmOne Advanced Medical Devices Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 KoKo PFT Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. France Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Italy Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 57. Asia Pacific Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 58. Asia Pacific Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 59. Asia Pacific Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 60. Asia Pacific Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. China Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. China Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 63. China Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 64. China Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 65. China Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 66. Japan Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 67. Japan Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Japan Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 69. Japan Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 70. Japan Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 71. India Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 72. India Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 73. India Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 74. India Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 75. India Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 76. South Korea Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. South Korea Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 78. South Korea Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 79. South Korea Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 80. South Korea Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 81. Australia Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 82. Australia Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 83. Australia Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 84. Australia Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 85. Australia Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 86. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 87. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 88. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 91. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 92. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 93. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 94. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 95. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End Use (US$ Mn)
Table 96. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 97. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 98. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 99. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 100. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 101. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 102. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 103. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 104. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 105. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 106. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 107. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 108. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 109. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 110. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 111. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 112. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 113. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 114. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 115. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 116. South & Central America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 117. South & Central America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South & Central America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 119. South & Central America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 120. South & Central America Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Pulmonary Function Testing Systems Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South & Central America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South & Central America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South & Central America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South & Central America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South & Central America Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Organic Growth Strategies in Pulmonary Function Testing Systems Market
Table 137. Recent Inorganic Growth Strategies in the Pulmonary Function Testing Systems Market
Table 138. Glossary of Terms
LIST OF FIGURES
Figure 1. Pulmonary Function Testing Systems Market Segmentation
Figure 2. Pulmonary Function Testing Systems Market, By Region
Figure 3. Global Pulmonary Function Testing Systems Market Overview
Figure 4. Cart-Based PFT System Segment Held Largest Share of Type Segment in Pulmonary Function Testing Systems Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Pulmonary Function Testing Systems Market, by Geography (US$ Million)
Figure 7. Global Pulmonary Function Testing Systems Market- Leading Country Markets (US$ Million)
Figure 8. Global Pulmonary Function Testing Systems Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East and Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Pulmonary Function Testing Systems Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Pulmonary Function Testing Systems Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Pulmonary Function Testing Systems Market– Revenue Forecast and Analysis – 2022 – 2028
Figure 18. Market Positioning of Key Players in Global Pulmonary Function Testing Systems Market
Figure 19. Pulmonary Function Testing Systems Market, by Type, 2021 & 2028 (%)
Figure 20. Cart-Based PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Stationary PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Pulmonary Function Testing Systems Market, by Test Type, 2021 & 2028 (%)
Figure 23. Spirometry: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Lung Volume: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Gas Exchange Testing: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Maximal Voluntary Ventilation: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Oxygen Titration Test: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Pulmonary Function Testing Systems Market, by Component, 2021 & 2028 (%)
Figure 30. Hardware: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Software: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Services: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Pulmonary Function Testing Systems Market, by Application, 2021 & 2028 (%)
Figure 34. Chronic Obstructive Pulmonary Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Asthma: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Chronic Shortness of Breath: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Restrictive Lung Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Pulmonary Function Testing Systems Market, by End-User, 2021 & 2028 (%)
Figure 40. Hospitals: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Specialty Clinics: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Diagnostic Laboratories: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. North America: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 44. North America Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. North America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 46. US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Europe: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 50. Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Europe: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 52. Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Asia Pacific: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 59. Asia Pacific Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East & Africa Pulmonary Function Testing Systems Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 67. Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 68. Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Country (%)
Figure 69. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 70. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 71. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 72. Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 73. South & Central America: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 74. South & Central America Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Figure 75. South & Central America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 76. Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 77. Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 78. Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 79. Impact of COVID-19 Pandemic on North American Country Markets
Figure 80. Impact of COVID-19 Pandemic in European Country Markets
Figure 81. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 82. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 83. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 84. Growth Strategies in Pulmonary Function Testing Systems Market
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pulmonary function testing systems market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in the global pulmonary function testing systems market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth global sports medicine devices market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Pulmonary Function Testing Systems Market
● SCHILLER
● COSMED srl
● MGC Diagnostics Corporation
● Ganshoran Medizin Electronic
● ndd Medical Technologies
● Morgan Scientific Inc.
● Pulm One Advanced Medical Devices Ltd
● CHEST M.I., Inc
● Vyaire Medical, Inc.
● Koko LLC
Lung Volume Segment to Account for Largest Share in Pulmonary Function Testing Systems Market During 2022–2028
According to the research study titled “the Pulmonary Function Testing Systems Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Test Type, Component, Application, and End User,” the market is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022 with an estimated CAGR of 6.6% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
In terms of revenue, Europe holds the second-largest share of the pulmonary function testing systems market in 2021. In Europe, Germany accounted for the largest market share in 2022. The UK is expected to register the highest CAGR in the Europe pulmonary function testing systems market from 2022 to 2028. According to the Public Library of Science (PLoS) report, chronic obstructive pulmonary disease (COPD) has grown to become the fourth leading cause of death globally. The current prevalence of COPD in Germany ranges from 1.3% to 13.2%. Also, the economic burden of COPD on the German healthcare system is high as the treatment for COPD is cost-intensive and is associated with high chances of work impairment..
Moreover, CF affects approximately one in 2,500 newborns in Germany. Therefore, for treating COPD among the German population, Statutory health insurance (SHI) acts as a core component of the German healthcare system. Additionally, cystic fibrosis (CF), a genetic condition, affects more than 8,000 children, adolescents, and adults in Germany as per the statistics revealed by Deutsches Zentrum für Lungenforschung (German Center for Lung Research, DZL) e. V. report. The SHI funds offer structured treatment programs intended for certain chronic diseases, including diabetes (type 1 and 2), breast cancer, coronary artery disease, asthma, and COPD. Further, with the high prevalence of asthma among the German population, the economic burden of the disease acts as a significant challenge for SHI. For example, pharmacotherapy and outpatient care account for significant healthcare costs related to asthma, with costs for in-patient care still considerable, with 23% of the asthma-related costs in Germany. With the high prevalence and healthcare expenditure of pulmonary disease among the German population, there is accelerating demand for pulmonary function testing systems.
Market Opportunities
Home Healthcare Pulmonary Function Testing Systems
The majority of lung function tests require specialized equipment that is only available for medical settings. However, at-home spirometers are available for patients with some lung diseases. For example, new approaches have enabled some at-home spirometry to be performed with the assistance of a tablet or smartphone. Various top companies are launching innovative products, particularly to perform sophisticated lung assessments at patients’ homes. For example, in 2016, American Respiratory Labs (ARL), a California-based mobile pulmonary function testing company, launched the “EasyOne PRO” product to perform sophisticated lung assessments at patients’ homes. The EasyOne Pro performs DLCO testing, spirometry, and full lung volumes anywhere in just 20 minutes. Moreover, EasyOne Pro provides accurate results through reliable ultrasound technology by eliminating calibration and maintenance costs. Further, after testing, the software enables American Respiratory Labs (ARL) to import PFT results into patients’ electronic health records. Additionally, at-home spirometry is often performed to assess a patient’s oxygen needs. Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) testing can determine shortness of breath caused due to respiratory or cardiac disease and differentiate between asthma and chronic obstructive pulmonary disorder (COPD) for appropriate treatment. Therefore, commercializing home healthcare pulmonary function testing systems products globally will offer lucrative market opportunities for the growth of the pulmonary function testing systems market in the forthcoming years.
Based on test type, the pulmonary function testing systems market is categorized into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration test, and others. The spirometry segment accounted for a 44.32% share of the pulmonary function testing systems market in 2022. Additionally, the lung volume segment is expected to register the highest CAGR during the forecast period. Spirometry is a medical test used to measure certain lung conditions. The test is used to diagnose and monitor the lungs’ capacity by measuring how much air can breathe out in one forced breath. The test is carried out with the help of medical devices called spirometry systems (PFT). The product used advanced software technology to provide accurate results.
The device can assist in diagnosing various respiratory diseases, such as obstructive chronic lung disease, emphysema, asthma, and other breathing disorders, for screening in an occupational environment. It is the gold standard for COPD diagnosis; however, the bulky size, complex functionality, and the need for regular maintenance are negatively impacting the acceptance of conventional spirometers by medical practitioners.
For instance, RMS Helios 401 is PC-based equipment is capable of diagnosing, differentiating and measuring various pulmonary diseases. The Helios series comes with a highly advanced and user-friendly software offering 34 parameter readings, pre-post bronchodilation results, percentage improvement and lung age calculations.
COSMED Srl, MGC Diagnostics Corp, Morgan Scientific Inc, Minato Medical Science Co Ltd, Schiller AG, Chest MI Inc, Vyaire Medical Inc, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, and KoKo PFT Ltd are among the leading companies operating in the global pulmonary function testing systems market.
Based on geography, the global pulmonary function testing systems market is primarily segmented into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South & Central America. The North America pulmonary function testing systems market is further segmented into the US, Canada, and Mexico. The Europe pulmonary function testing systems market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Asia Pacific pulmonary function testing systems market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The pulmonary function testing systems market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of MEA. The South & Central America pulmonary function testing systems market is subsegmented into Brazil, Argentina, and the Rest of South & Central America.
Related Reports
- $3,000.00 – $5,000.00
